 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Abstract
We previously demonstrated that overexpression of homeoprotein Six1 in hepatocellular carcinoma (HCC) patients is associated with venous infiltration, advanced pathologic tumor metastasis (pTNM) stage and poor overall survival rate 1 . In this study, short hairpin RNA (shRNA) interference approach was used to suppress the expression of Six1 in a metastatic more than 600 000 deaths per year 2 . Surgical treatments in terms of hepatic resection and orthotopic liver transplantation are frontline treatments for HCC, but the long-term disease-free survival remains unsatisfactory 3, 4 . Tumor recurrence and metastases are the major causes of death in HCC patients after surgical treatments 5, 6 , indicating the necessity of developing new therapeutic strategies targeting at tumor recurrence and metastases in HCC.
Up to now, the molecular mechanisms of HCC metastasis remain unclear; hence identification and characterization of novel metastasis-associated genes are indispensable for development of effective treatment of HCC patients.
Homeoprotein Six1 belongs to a subfamily of the Six family of homeodomain-containing transcription factors that shares a lysine within the DNA-binding helix of the homeodomain 7, 8 . Six1, located at 14q23 of the chromosome is involved in early developments of diverse organs such as the brain, ear, eye, muscle and kidney [8] [9] [10] [11] [12] . Alteration of Six1 expression takes place in human breast cancer, Wilms' cancer, ovarian cancer and rhabdomyosarcoma, indicating its possible contributions in the tumorigenicity of different cancers [13] [14] [15] [16] . Six1 is also regarded as an important metastatic regulator in cancers. For example, overexpression of Six1 occurs in a large percentage of primary cancers, and strongly correlates with breast lesions 15 . Six1 elevated in breast cancer promotes progression of breast cancer 17 . Six1 also plays a substantial role in regulating the metastatic ability of rhabdomyosarcoma 13 . The impact of Six1 on promoting tumorigenesis and metastasis of multiple cancers therefore impelled us to study the property of Six1 in HCC. We previously found that Six1 protein is specifically overexpressed in tumor tissues rather than non-tumor tissues of HCC patients.
Overexpression of Six1 protein is significantly associated with venous infiltration, advanced F o r P e e r R e v i e w 5 pathologic tumor metastasis (pTNM) stage and poor overall survival of HCC patients after surgical resection 1 . Also, in vitro gene expression analysis found that Six1 protein is specifically expressed in metastatic HCC cells but not in non-metastatic HCC cells 1 .
In the present study, we suppressed the expression of Six1 in a metastatic HCC cell using short hairpin RNA (shRNA) interference technique to study the possible roles of Six1 in proliferative and metastatic abilities of HCC through in vitro and in vivo functional assays.
Furthermore, cDNA microarray approach was employed to identify possible downstream targets of Six1 shedding some light on the regulation mechanism via in HCC. 
Material and methods

Cell lines
A human metastatic HCC cell line MHCC97L was a gift from Liver Cancer Institute & 
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted by using RNeasy Mini Kit (Qiagen , sense AAG GAG AAG TCG AGG GGT GT, antisense TGC   TTG TTG GAG GAG GAG TT; for 18S ribosomal RNA, sense CTC TTA GCT GAG TGT CCC GC, antisense. CTG ATC GTC TTC GAA CCT CC.
Western blot analysis
Proteins were extracted by 1X Lysis Buffer (Cell Signaling Technology). Protein extracts were separated by 12% SDS-PAGE and transferred to PDMF membrane (Millipore). After blocking with 5% non-fat milk for 1 hour, antibody, appropriately diluted, was hybridised with the membrane at 4 o C over night. The membrane was washed 3 times with TBS/T each for 10 minutes and incubated with secondary antibody for 1 hour at room temperature. Protein signal was detected by ECL Plus system (GE Healthcare). Antibodies Six1 and β-Actin were purchased from Santa Cruz Biotechnology.
Ultrastructural examination by scanning electron microscopy
Cells grown on the cover-slips were fixed with 2.5% glutaraldehyde in 0. 
Colony formation assay
Five hundreds of cells were seeded onto 6-well plate and incubated in normal condition.
After 2 weeks cultivation, cells were fixed by ice-cold methanol for 30 minutes and stained by
Crystal violet for 10 minutes. Colonies (more than 50 cells) were counted directly on the plate.
Statistical significant was calculated from each four independent experiments. 
Cell cycle analysis
Collagen type I assay
In vivo tumorigenicity model
Cells (2x10 6 ) were suspended in 150µl of saline and subcutaneously injected into each nude mouse. The tumor size and body weight were measured for every 5 days. After 6 weeks, the mice were sacrificed and the tumors were harvested for further analysis. Six mice were recruited for each of the experimental group. Volume of the tumor was calculated as follows:
tumor volume (cm 3 ) = 1/2 x larger size x smaller size 2 .
In vivo experimental and spontaneous metastasis models
In vivo experimental metastasis model was established by injection of 2x10 6 
Confirmation of cDNA microarray data by SYBR green real-time RT-PCR
Statistical analysis
Statistical analysis was carried out using SPSS 16.0 for Windows (SPSS Inc., IL).
Two-tailed Student's t test was used for analysis of continuous variables. P < 0.05 was considered to be statistically significant. 
Results
Suppression of Six1 expression by shRNA
MHCC97L, a HCC cell line with metastatic potential to lung 18 , overexpresses Six1 gene compared with other non-metastatic HCC cells 1 . To investigate the role of Six1 in HCC metastasis, MHCC97L was transfected with DNA based Six1-specific shRNA plasmid (pGE-1-shSix1) and control plasmid (pGE-1-Control). The expression level of Six1 gene was suppressed by more than 2-folds in MHCC97L-shSix1 cell, both in mRNA ( Fig. 1a) and protein ( Fig. 1b) levels, compared to MHCC97L-control cell. Microscopically, the morphology of MHCC97L-shSix1 was changed to a rounder and more compressed shape compared with MHCC97L-Control (Fig. 1c) . Under electron microscope (EM) analysis, MHCC97L-shSix1 displayed less numbers of extracellular "hair-like" connection fibres (lamellipodia formation) compared to MHCC97L-Control (Fig. 1d ).
Effect on cell proliferation and colony formation
To investigate the effect of Six1 suppression on cell growth, MTT assay was employed to analyse the growth rate of MHCC97L-shSix1 and MHCC97L-Control for 5 days. Compared with MHCC97L-Control, MHCC97L-shSix1 exhibited slower growth rate and reached 2-fold difference on day 4 (Fig. 2a) . Statistical analysis, by t-test, showed significant difference between 2 groups on day 2, 3, 4 and 5 (P < 0.01). Moreover, the number of colony formed in MHCC97L-shSix1 were significantly less than that in MHCC97L-Control (23 vs 108 in average, p=0.000, Fig. 2b ).
Effect on cell cycle
To examine the effect of Six1 suppression on the cell cycle, DNA content of MHCC97L-shSix1 and MHCC97L-Control was analyzed by FACS using propidium iodide (PI) staining. The cells were subjected to serum starvation for 3 days for synchronization of the cells in G 0 phase, followed by re-supplementation of 10% serum for 2 days. The percentage of G2/M phase of MHCC97L-shSix1 were consistently higher than that of MHCC97L-Control on day 0, 1 and 2 (Fig. 3a) . These results demonstrated that suppression of Six1 expression leads to a delay in G2/M transition (Fig. 3b) .
Effect on cell motility and invasion
To investigate the effect of Six1 suppression on cell motility, three common methods including wound healing assay, migration assay and collagen type I invasion assay were performed on MHCC97L-Control and MHCC97L-shSix1 cells. Wound healing assay at 24
hours after the creation of straight wound line showed that the wound in MHCC97L-Control almost recovered while the wound in MHCC97L-shSix1exhibitted only slight improvement (Fig. 4a) . It was estimated that the wound-healing ability of MHCC97L-shSix1 was at least 
Effect on distribution of F-actin
Phalloidin staining of MHCC97L-Control after LPA stimulation showed that F-actin was evenly distributed all over the cells (Fig. 5) . While in MHCC97L-shSix1, F-actin expression 
Effect on in vivo metastasis
We performed experimental and spontaneous metastasis models to evaluate the effect of Six1 suppression on metastatic behaviours of MHCC97L cell line. For the experimental metastasis model, 6 weeks after inoculation, 3 of 7 (42.9%) mice were found to have pulmonary metastasis by H&E staining in MHCC97L-Control group (Fig. 7a) , while there is no pulmonary metastasis in MHCC97L-shSix1 group. No liver tumor was found in both groups (Table II) . However, the difference between these two groups was statistically insignificant (Table II) .
For the spontaneous metastasis model, 6 weeks after the implantation, it was found that less liver tumor formed in MHCC97L-shSix1 group (6 of 8, 75%) compared to that of the MHCC97L-Control group (8/8, 100%). Moreover, the average size of liver tumor in MHCC97L-shSix1 group was noticeably smaller than that of the MHCC97L-Control group ( Fig. 7b and Table II) . Furthermore, the aggressive phenotype of tumor was attenuated in (Fig. 7b) . Lastly, H & E staining of lung section (Fig. 7b) revealed that more than 60% (5 of 8) of mice in MHCC97L-Control group showed pulmonary metastasis while no pulmonary metastasis case was developed in MHCC97L-shSix1 group (Table II) . Statistical analysis indicated that both tumor volume (p=0.000) and metastasis potential (p=0.026) in MHCC97L-shSix1 group were significantly reduced compared to MHCC97L-Control group (Table II) .
Identification of downstream targets of Six1
To find out the genes under the regulation of Six1, gene expression profiles of MHCC97L-shSix1 were compared with MHCC97L-Control using cDNA microarray analysis.
A total of 61 down-regulated and 59 up-regulated differential targets were found in MHCC97L-shSix1 compared to that in MHCC97L-Control. After screening out those unknown genes and EST sequences, a total of 28 down-regulated and 24 up-regulated genes with known functions were identified (Tables III and IV) . A summary for down-regulated and up-regulated genes was generated based on their functions (Fig. 8) .
To validate the cDNA microarray results, 15 either down-regulated or up-regulated genes that have higher fold changes among samples were selected and confirmed by SYBR green real-time semi-quantitative RT-PCR (sqRT-PCR). Dissociation curve for each gene was tested to make sure that only a specific PCR product indicated by production of a single peak was generated for each pair of primers (data not showed). Otherwise, new pairs of primers were redesigned and retested. The Ct value for each gene was normalized with the Ct value of 18S primers. For down regulated genes, most of the results from sqRT-PCR were consistent with the findings from cDNA microarray analysis (Table III) . For up-regulated genes, sqRT-PCR results showed higher fold changes than the microarray analysis (Table IV) .
Genes differentially expressed upon suppression of Six1 gene were found to be involved in The mechanism of Six1 in G2/M regulation and the relationship with cell cycle regulators in HCC remains to be determined.
MHCC97L is a metastatic HCC cell line which can metastasize to lung from liver 21 . Our data showed that suppression of Six1 expression in this cell line resulted in inhibition of its in vitro metastatic activities including wound-healing, migration and invasion abilities.
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